Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,519.5
-10.8 (-0.43%)

 

  • STI Straits Times Index
    2,519.5
    -10.8 (-0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,451.7
    15.0 (1.04%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,301.4
    -83.3 (-0.36%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,836.8
    -9.7 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,419.2
    148.1 (0.70%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,641.6
    14.8 (0.32%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,345.0M
  • Value: 1,392.6M
  • Rise: 148
  • Fall: 146
  • Unch: 514

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Reenova Investment^0.003+0.001
Medtecs Intl0.235+0.045
Rex Intl0.143-0.001
UG Healthcare0.450+0.080
Clearbridge0.200+0.016
Singtel2.620-0.040
Singapore-eDev0.056+0.003
ComfortDelGro1.530-
Genting Sing0.780+0.020
Mapletree Log Tr1.900+0.010

World Indices

World Indices
Name Last Change
Nasdaq 9,340.2 +15.6
HSI 23,301.4 -83.3
HSCEI 9,567.4 -27.8
Jakarta 4,641.6 +14.8
Nikkei 225 21,419.2 +148.1
SSE Comp 2,836.8 -9.7
Shanghai A 2,973.3 -10.2
Shanghai B 207.0 -1.1
KOSPI 2,031.2 +1.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 KONINKLIJKE PHILIPS N.V. SPONSORED ADR
Updated on 26 May 2020 (End of trading day)
Last (USD): 44.690 Change: +0.170 High: 45.400 Remarks: -
Change (%): +0.38 Low: 44.675
Open 45.290 Yesterday's Close 44.519999999999996
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 663,181 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.45658 Trailing EPS (USD) e 1.45658 NAV (USD) b 15.7685
PE a 30.681 Trailing PE f 30.681 Price / NAV b 2.8341
Dividend (USD) d 0.914885 Cash In Hand (USD) g 1.7838 Issued & Paid-up Shares c 896,734,000
Dividend Yield (%) d 2.047 Price / Cash In Hand g 25.053 Treasury Shares h 5,759,931
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 40,075.042
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 44,621.167
Piotroski F Score 8 Exchange Code PHG Par Value ( $ ) n.a.
52 Weeks Volatility (%) 35.37 Free Float (%) -
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Jan 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Mar 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 40,075.042 30.681 30.681 2.8341 2.047
Industry Medical Specialties NYSE 28,412.056 32.966 34.359 3.8632 0.767
Local Peer ABBOTT LABORATORIES NYSE 158,276.698 43.174 44.724 5.2378 1.470
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 131,348.854 35.538 35.800 4.5992 0.231
Local Peer MEDTRONIC PLC NYSE 130,284.951 27.205 27.205 2.5679 2.223
Local Peer DANAHER CORP NYSE 112,119.232 45.049 40.964 3.8064 0.422
Local Peer STRYKER CORP NYSE 69,830.456 33.524 32.269 5.3245 1.145
Local Peer BECTON DICKINSON & CO NYSE 67,559.309 62.439 74.241 3.2249 1.241
Local Peer BOSTON SCIENTIFIC CORP NYSE 50,642.476 10.775 11.813 3.6687 -
Local Peer EDWARDS LIFESCIENCES CORP NYSE 44,824.501 42.816 40.463 11.4902 -
Local Peer BAXTER INTERNATIONAL INC NYSE 43,510.566 43.467 42.616 5.6515 0.989
Local Peer ALCON AG NYSE 30,160.878 - - 1.5733 -
Local Peer ZIMMER BIOMET HOLDINGS INC NYSE 26,210.085 23.162 69.523 2.2065 0.755
Local Peer RESMED INC NYSE 23,216.321 57.382 45.288 10.2890 0.941
Other Local Peers METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE), RA MEDICAL SYSTEMS INC (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 65,433.194 47.439 47.200 7.6920 -
Global Peer DEXCOM INC NASDAQ 35,239.217 348.558 238.264 37.7091 -
Global Peer IDEXX LABORATORIES INC NASDAQ 24,701.914 57.753 56.543 229.4053 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 19,902.397 85.414 86.053 - -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 19,525.323 44.098 10.336 6.8438 -
Global Peer HOLOGIC INC NASDAQ 13,194.327 - 21.412 6.3249 -
Global Peer MASIMO CORPORATION NASDAQ 12,723.613 64.845 60.202 10.1522 -
Global Peer INSULET CORPORATION NASDAQ 12,018.880 1,036.081 2,331.952 203.7144 -
Global Peer FISHER & PAYKEL HEALTHCARE CORP ASX 16,485.870 84.409 74.815 19.3019 0.888
Global Peer DENTSPLY SIRONA INC NASDAQ 9,930.896 37.774 118.507 2.1186 0.836
Other Global Peers ABIOMED INC (NASDAQ), HARTA (Bursa), COCHLEAR LTD (ASX), Top Glove (SGX), TOPGLOV (Bursa), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), BRUKER CORPORATION (NASDAQ), NOVOCURE LTD (NASDAQ), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), AK MEDICAL (HKEx), VENUS MEDTECH-B (HKEx), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), EBOS GROUP (ASX), ATRICURE INC (NASDAQ), PEIJIA-B (HKEx), SUPERMX (Bursa), STAAR SURGICAL CO (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), NANOSONICS LIMITED (ASX), SHOCKWAVE MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CAREDX INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), KDL MEDICAL (HKEx), MESA LABORATORIES INC (NASDAQ), CERUS CORP (NASDAQ), INMODE LTD (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), LIFETECH SCI (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), INOGEN INC (NASDAQ), HESKA CORP (NASDAQ), NATUS MEDICAL INC (NASDAQ), CIRC (HKEx), VAREX IMAGING CORPORATION (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), QUOTIENT LTD (NASDAQ), VERICEL CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SURMODICS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), SI BONE INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ACCELERATE DIAGNOSTICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), AXOGEN INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), YESTAR HEALTH (HKEx), TRANSMEDICS GROUP INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), STEREOTAXIS INC (NYSE American), CORMEDIX INC (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), PW MEDTECH (HKEx), IRADIMED CORP (NASDAQ), VIEWRAY INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), CUTERA INC (NASDAQ), MISONIX INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), GOLDEN MEDITECH (HKEx), DERMTECH INC (NASDAQ), PROFOUND MED CORP (NASDAQ), SIENTRA INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), ALPHA PRO TECH (NYSE American), SOLENO THERAPEUTICS INC (NASDAQ), MODERN DENTAL (HKEx), RETRACTABLE TECHNOLOGIES INC (NYSE American), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), TELA BIO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), INTRICOM CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ONCOCYTE CORP (NYSE American), CELSION CORPORATION (NASDAQ), Medtecs Intl (SGX), RESAPP HEALTH LIMITED (ASX), VOLITIONRX LIMITED (NYSE American), Biolidics (SGX), CYCLOPHARM LIMITED (ASX), BIOMERICA INC (NASDAQ), CONFORMIS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), YUNNAN ENERGY (HKEx), NEPHROS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), UG Healthcare (SGX), SDI LTD (ASX), VINCENT MED (HKEx), COMPUMEDICS (ASX), IMPEDIMED LIMITED (ASX), RESONANCE HEALTH LTD (ASX), SOMNOMED LIMITED (ASX), DAXOR CORP (NYSE American), EMVISION MEDICAL DEVICES LTD (ASX), LKL (Bursa), ZOSANO PHARMA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), KELFRED (HKEx), THERMOGENESIS HOLDINGS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), NEURONETICS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), ELECTROCORE INC (NASDAQ), MICRO-X LTD (ASX), SENSUS HEALTHCARE INC (NASDAQ), NEOVASC INC (NASDAQ), DIMERIX LTD (ASX), NEUROTROPE INC (NASDAQ), Yunnan Energy (SGX), IMMUCELL CORP (NASDAQ), RESPIRI LTD (ASX), OVENTUS MEDICAL LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), XTANT MEDICAL HLDGS INC (NYSE American), LBT INNOVATIONS LTD (ASX), DARIOHEALTH CORP (NASDAQ), IRIDEX CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), USCOM LTD (ASX), ATOSSA THERAPEUTICS INC (NASDAQ), LIFE HEALTHCARE (HKEx), TITAN MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), CHECK-CAP LTD (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), ENDOLOGIX INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), OPTISCAN IMAGING (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CYANOTECH CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), Annica (SGX), TENAX THERAPEUTICS INC (NASDAQ), CARDIEX LTD (ASX), AVINGER INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), DYNATRONICS CORP (NASDAQ), ADHERIUM LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), ANALYTICA (ASX), METALICITY LIMITED (ASX), CANCER GENETICS INC (NASDAQ), INSPIREMD INC (NYSE American), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), STHAI (SET), DIGIRAD CORP (NASDAQ), DORSAVI LTD (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.440
-0.97 %
10 Days -+2.540
+6.03 %
20 Days -+1.630
+3.79 %
Medium Term Return 3 Months -+1.190
+2.74 %
6 Months --1.740
-3.75 %
1 Year -+5.110
+12.91 %
Long Term Return 2 Years -+2.990
+7.17 %
3 Years -+9.370
+26.53 %
5 Years -+17.010
+61.45 %
Annualised Return Annualised --
+10.05 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 30.500 - 50.780 Change From 1 Year Low +14.190 % Change From 1 Year Low (%) +46.52
Change From 1 Year High -6.090 % Change From 1 Year High (%) -11.99
2 Years Range 30.500 - 50.780 Change From 2 Years Low +14.190 % Change From 2 Years Low (%) +46.52
Change From 2 Years High -6.090 % Change From 2 Years High (%) -11.99
5 Years Range 22.995 - 50.780 Change From 5 Years Low +21.695 % Change From 5 Years Low (%) +94.35
Change From 5 Years High -6.090 % Change From 5 Years High (%) -11.99
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Historical Price Data

Date Open High Low Close Volume VWAP
26 May 2020 45.290 45.400 44.675 44.690 663,181 -
22 May 2020 44.030 44.550 43.940 44.520 594,565 -
21 May 2020 45.530 45.550 44.670 44.720 732,799 -
20 May 2020 44.980 45.490 44.640 45.130 1,292,971 -
19 May 2020 43.350 43.670 43.010 43.010 893,887 -
18 May 2020 42.290 43.440 42.220 43.250 1,041,206 -
15 May 2020 40.910 41.260 40.810 41.240 704,332 -
14 May 2020 40.830 41.070 40.540 41.070 1,162,037 -
13 May 2020 42.640 42.750 41.980 42.150 1,418,953 -
12 May 2020 42.990 43.020 41.690 41.710 2,294,959 -
11 May 2020 42.620 42.890 42.460 42.730 2,210,912 -
08 May 2020 42.970 43.450 42.790 43.310 1,302,531 -
07 May 2020 42.930 43.040 42.470 42.870 1,729,800 -
06 May 2020 43.040 43.300 42.685 42.700 1,586,934 -
05 May 2020 42.880 43.840 42.740 43.150 1,013,005 -
04 May 2020 42.610 42.851 42.260 42.770 851,284 -
01 May 2020 43.420 43.545 42.670 42.850 936,942 -
30 Apr 2020 43.570 43.970 43.020 43.910 1,278,884 -
29 Apr 2020 42.970 43.270 42.775 43.060 877,726 -
28 Apr 2020 44.020 44.030 43.210 43.250 1,483,241 -
27 Apr 2020 43.630 43.780 43.423 43.660 524,375 -
24 Apr 2020 42.760 43.300 42.620 43.200 567,018 -
Summary
Current 2 Weeks
(12 May 2020 to 26 May 2020)
42.990 45.550 40.540 44.690 10,798,890 -
Previous 2 Weeks
(28 Apr 2020 to 11 May 2020)
44.020 45.550 40.540 42.730 13,271,259 -
4 Weeks from
(30 Mar 2020 to 27 Apr 2020)
40.470 45.550 40.030 43.660 24,146,693 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.